Question 1

What is Arbutus Biopharma Corporation's deferred tax assets and other non-current assets?

Accepted Answer

Arbutus Biopharma Corporation (ABUS) reported deferred tax assets and other non-current assets of $131K in Q1 2026.

Question 2

How has Arbutus Biopharma Corporation's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Arbutus Biopharma Corporation's deferred tax assets and other non-current assets increased by 285.3% year-over-year, from $34K to $131K.

Question 3

What is the long-term trend for Arbutus Biopharma Corporation's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's deferred tax assets and other non-current assets has grown at a 24.2% compound annual growth rate (CAGR), from $44K to $130K.

Line item	March 31, 2026	December 31, 2025
Prepaid expenses and other current assets	1,732	1,538
Total current assets	277,011	94,456
Property and equipment, net of accumulated depreciation and impairment of $224 (December 31, 2025: $213)	22	32
Other non-current assets	131	130
Total assets	$277,164	$94,618
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$4,474	$5,459

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Arbutus Biopharma Corporation's deferred tax assets and other non-current assets.

Arbutus Biopharma Corporation ABUS Deferred Tax Assets and Other Non-Current Assets